<narrative xml:lang="en">Investing to Reduce the Burden of Tuberculosis and HIV in the Democratic Republic of the Congo. - Congo (Democratic Republic) (01-Jan-2024-31-Dec-2026)</narrative>

47045-COD-C-MOH-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative xml:lang="en">Investing to Reduce the Burden of Tuberculosis and HIV in the Democratic Republic of the Congo. - Congo (Democratic Republic) (01-Jan-2024-31-Dec-2026)</narrative> Congo (Democratic Republic), TB/HIV, Ministry of Public Health, Hygiene and Social Security (MOH DRC)This program has the following goals: Contribuer à l'accéleration du progres vers la fin de l'épidemie de la TB en RDC / Contribute to accelerating progress towards the end of the TB epidemic in DRC. OBJECTIF GENERAL du Plan Stratégique National 2024-2028 de lutte contre la tuberculose est de contribuer à l'élimination de la TB en RDC / GENERAL OBJECTIVE of the National Strategic Plan 2024-2028 to combat tuberculosis is to contribute to the elimination of TB in the DRC.. Faire de la RDC un pays avec « ZERO nouvelle infection, ZERO décès lié au VIH/Sida et ZERO discrimination et stigmatisation » dans la perspective qu’en RDC, le VIH ne soit plus un problème de santé Publique à l’horizon 2030. / To make the DRC a country with ZERO new infections, ZERO HIV/AIDS-related deaths, and ZERO discrimination and stigmatization so that by 2030, HIV will no longer be a public health problem in the DRC.. The objectives of this program are: Dépister un total cumulé de 854 736 cas de TB toutes formes dans le cadre du GC7 parmi lequel 137 901 enfants et 6330 cas de TBMR / Screen a cumulative total of 854,736 cases of all forms of TB within the framework of GC7, including 137,901 children and 6,330 cases of MDR-TB. Traiter avec succès au moins 95% des patients TB PS notifiés et au moins 85 % des TB MR notifiés; / Successfully treat at least 95% of notified SP-TB patients and at least 85% of notified MDR-TB patients;. Mettre sous traitement d’infection latente enfants de moins de 5 ans en contact avec des cas TB+ exclue de la TB (352 801) ; / Put on treatment for latent infection children under 5 years of age in contact with TB+ cases excluded from TB (352,801);. Tester au VIH au moins 90% des patients tuberculeux notifiés durant la période ; / Test at least 90% of TB patients notified during the period for HIV;. Mettre sous ARV 95% des patients coïnfectés (TB VIH+) durant la période dans le pays ; / Put 95% of co-infected patients (HIV+ TB) on ARVs during the period in the country;. Réduire les nouvelles infections VIH de 95% d’ici 2027 / Reduce new HIV infections by 95% by 2027. Réduire les nouvelles infections chez les nourrissons nés des mères infectées par le VIH de 98 % d'ici 2027 / Reduce new infections among infants born to HIV-infected mothers by 98% by 2027. Réduire la mortalité liée au VIH de 9.5% à 7.4% / Reduce HIV-related mortality from 9.5% to 7.4% by the end of 2027. Reduire la discrimination, la stigmatisation et les inégalités sociales liées au VIH/TB à l’égard des PVVIH, populations clés (Transgenre, HSH, PS, UDI, PS, détenus ) et autres populations vulnérables (SVS, SVBG et OEV) de 95% d’ici fin 2027 / Reduce discrimination, stigma and social inequalities related to HIV/TB for PLHIV, key populations (Transgender, MSM, PS, IDU, PS, prisoners) and other vulnerable populations (SVS, SVBG and OVC) by 95% by the end of 2027. Soutenir la riposte nationale VIH par une bonne gouvernance et une coordination multisectorielle optimale à tous les niveaux d’ici à 2027 / Support the national HIV response through good governance and optimal multisectoral coordination at all levels by 2027

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Ministry of Public Health, Hygiene and Social Security

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division

Sonia, FLORISSE

Fund Portfolio Manager

+41 58 791 1700 sonia.florisse@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Congo (Democratic Republic)

HIV Multicomponent RSSH Tuberculosis

HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Retention support for pregnant and breastfeeding women (facility and community)

HIV -> Prevention package for people in prisons and other closed settings -> HIV prevention communication, information and demand creation for prisoners

HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> HIV prevention communication, information and demand creation for PUD

HIV -> Prevention program stewardship -> Prevention program stewardship

HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights

HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings

HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care

HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB)

HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy (“Know Your Rights”) (HIV/TB)

HIV -> Treatment, care and support -> Diagnosis and management of advanced disease (adults and children)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15)

HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children)

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Health products management systems -> Storage and distribution capacity, design & operations

RSSH -> RSSH: Health products management systems -> Supply chain information systems

RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use

RSSH -> RSSH: Monitoring and evaluation systems -> Data quality

RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting

RSSH -> RSSH: Monitoring and evaluation systems -> RSSH/PP: Surveillance for priority epidemic-prone diseases and events

RSSH -> RSSH: Monitoring and evaluation systems -> Surveys

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: National laboratory governance and management structures

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation

Tuberculosis -> Collaboration with other providers and sectors -> Collaboration with other programs/sectors

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST)

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support

Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Miners and mining communities

Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs)

Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis

Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

16530720.74

5218492.87

8229195.60

-471033.14 Global Fund Commitment to COD-C-MOHP01.

Global Fund to Fight AIDS, Tuberculosis and Malaria